跳至主要内容
临床试验/NCT05903664
NCT05903664撤回不适用

Retinal Deep PhenotypingTM by A Novel Mydriatic Hyperspectral Retinal Camera (MHRC) And Analysis by Deep Learning

Optina Diagnostics Inc.1 个研究点 分布在 1 个国家开始时间: 2023年11月30日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
1
主要终点
At least one (1) Deep Learning (DL) model that characterizes the retina.

研究概览

简要总结

This study aims to collect a baseline dataset of MHRC retinal scans that will be used for the pre-training of deep learning models from the hyperspectral retinal image phenotypic features that may form the basis for multiple future classification applications.

As an exploratory study, there are no endpoints per se, however, the following sub-objective will be evaluated for determining the success of this study:

  • Collection and characterization of MHRC retinal images from at least 250 participants that score at least 80 on the real-time Quality Index (included in the MHRC software).
  • Development of at least one (1) DL model of the retina. Models may be used for the development of novel classifier tests and potential use in a clinical setting.

详细描述

This is an exploratory, observational, cross-sectional, multi-site study designed to collect a baseline dataset of MHRC retinal image scans for use in Deep Learning models. Subjects will be recruited from eye clinics where patients will undergo mydriasis (pupil dilation) as part of their clinical visit. Eligible participants will be provided information about the study and delegated site personnel will assist with the Informed Consent process. If a participant provides their Informed Consent, they will be enrolled in the study and undergo a single retinal imaging session with the Optina MHRC device, on one or both eyes.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults 18 years and older who will undergo mydriasis (pupil dilation) as part of their eye clinic visit.

排除标准

  • Contraindications for mydriatic fundus imaging.
  • Pupil dilation contraindicated (due to a pathology, or presence of 3 quadrants with Van Herick grading of 0 or 1 without iridotomy).
  • Inadequate pupil dilatation (< 6mm diameter) preventing uniform illumination of the retina with the MHRC.
  • Refractive error outside the range of -15 D to +15 D.
  • Deficient visual fixation (inability to fixate for at least 2 s)
  • Inability of obtaining at least 3 images of satisfactory quality with the MHRC per the Optina Diagnostics quality index software and /or per the eye specialists' evaluation.

结局指标

主要结局

At least one (1) Deep Learning (DL) model that characterizes the retina.

时间窗: 12 months

Review of any safety events (AE, SAE, UADEs) that occur throughout the study.

时间窗: 12 months

As an exploratory study, there are no acceptance criteria for these study outcomes, rather the study results will be summarized in a Final Clinical Study report that will document the study outcomes and any learnings/models that may be applied to new development project using the MHRC H5 images

次要结局

未报告次要终点

研究者

发起方
Optina Diagnostics Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Retinal Deep Phenotyping.TM | 临床试验